Section 8 – Other Events

Item 8.01  Other Events.

On April l, 2013, Visualant, Inc. (the “Company”), an industry-leading provider of chromatic-based authentification, identification and diagnostic solutions, announced today that it received its fifth patent on its ChromaID™ technology. The latest patent further validates the company’s vision to introduce more efficient authentication, identification and diagnostic methods into the marketplace, and comes shortly after Visualant was awarded the prestigious PRISM award at the SPIE Photonics West trade show in San Francisco.

Future devices embedded with ChromaID™ technology can read and record natural chromatic markers by structuring light onto a substance, through a liquid or gas, or off a surface. Once scanned, the technology captures the reflected light using a simple Photodiode array and creates a unique ChromaID profile. The ChromaID profile can be matched against existing databases to identify, detect, or diagnosis markers invisible to the human eye. The latest patent extends the reach of Visualant’s intellectual property to cover medical diagnostics.

The patent issued by the United States Office of Patents and Trademarks is US Patent No. 8,368,878 B2 and is entitled “Method, Apparatus and Article To Facilitate Evaluation of Object Using Electromagnetic Energy.”

Item 9.01  Financial Statements and Exhibits.

(d)     Exhibits –

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EXHIBIT INDEX

- 2 -